The present invention encompasses heterologous fusion 5 proteins comprising a hyperglycsoylated G-CSF analog fused to proteins such as albumin and the Fc portion of animmunoglobulin which act to extend the in vivo half-life of the protein compared to native G-CSF. These fusion proteins are particularly suited for the treatment of conditions 10 treatable by stimulation of circulating neutrophils, such as after chemotherapy regimens or in chronic congenital neutropenia.

 
Web www.patentalert.com

< Methods for Detecting Isolates of the Potato Virus (Pvy) Responsible for Necroses

> Dna Sequence, and Recombinant Preparation of Group 4 Major Allergens From Cereals

~ 00429